STRS OHIO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 63 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
STRS OHIO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$218
-22.4%
6,9000.0%0.00%0.0%
Q2 2023$281
-53.4%
6,900
-57.4%
0.00%0.0%
Q1 2023$603
+27.2%
16,200
+19.1%
0.00%
-50.0%
Q4 2022$474
-99.9%
13,600
-14.5%
0.00%
-50.0%
Q3 2022$889,000
+8.2%
15,9000.0%0.00%0.0%
Q2 2022$822,000
-24.6%
15,900
+6.0%
0.00%0.0%
Q1 2022$1,090,000
-40.9%
15,000
-3.8%
0.00%
-33.3%
Q4 2021$1,844,000
-19.1%
15,600
-8.2%
0.01%
-33.3%
Q3 2021$2,280,000
-13.6%
17,000
+4.3%
0.01%0.0%
Q2 2021$2,639,000
+147.3%
16,300
+22.6%
0.01%
+125.0%
Q1 2021$1,067,000
+80.2%
13,300
+22.0%
0.00%
+100.0%
Q4 2020$592,00010,9000.00%
Q1 2017$0
-100.0%
0
-100.0%
0.00%
Q4 2016$41,000
-24.1%
3,2000.0%0.00%
Q3 2016$54,000
+10.2%
3,200
+39.1%
0.00%
Q2 2016$49,0002,3000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 744,160$54,078,0005.79%
Discovery Value Fund 986,173$71,665,0005.28%
Ally Bridge Group (NY) LLC 60,000$4,360,0003.23%
MPM BioImpact LLC 159,409$11,584,0003.11%
ARK Investment Management 8,981,029$652,651,0002.72%
Elmwood Wealth Management, Inc. 67,599$4,912,0002.52%
Nikko Asset Management Americas, Inc. 2,872,269$192,442,0001.41%
Frazier Life Sciences Management, L.P. 203,684$14,802,0001.26%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$8,098,0001.22%
Merlin Capital, Inc 11,575$841,0001.11%
View complete list of INTELLIA THERAPEUTICS INC shareholders